Transboundary And Emerging Diseases

Journal Title：Transboundary And Emerging Diseases

Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):

Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.

Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.

Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.

Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).

Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.

《跨界和新興疾病》匯集了對全球動物和人類造成最大經濟威脅的傳染病的最新研究成果。該期刊為全球有關其診斷、預防和管理的研究提供了一個平臺，也為有關公共衛生、發病機制、流行病學、統計建模、診斷、生物安全問題、基因組學、疫苗開發和新疫情快速通報的論文提供了一個平臺。論文應包括使用最先進技術的及時研究方法。編輯鼓勵論文采用基于科學的方法研究影響這些疾病造成的生物安全威脅管理的社會經濟和環境因素，包括風險分析和疾病傳播建模。將優先考慮以控制跨界和新興疾病的新型科學方法為重點的通信。以下主題通常被認為超出范圍，但會根據具體情況做出決定（例如，對隱蔽野生動物種群的研究和對潛在物種滅絕的研究）：

病原體發現：在特定國家新發現的常見病原體，或一種新的病原體或基因序列，關于其出現或傳播的背景或見解很少。

基于調查（而非縱向）方法的患病率估計調查和風險因素研究，除非此類研究是獨一無二的。知識、態度和實踐調查在范圍內。

如果沒有從實地研究中獲得可靠的敏感性和特異性估計，則進行診斷測試開發。

僅關注實驗室方法的研究，其中與疾病出現和傳播的相關性不明顯或無法推斷（“純研究”類型的研究）。

不會產生新知識的敘述性文獻綜述。系統評價和范圍評價以及薈萃分析均在范圍內。

Transboundary And Emerging Diseases創刊于2008年，由Wiley-Blackwell Publishing Ltd出版商出版，收稿方向涵蓋農林科學 - 傳染病學全領域，此刊是該細分領域中屬于非常不錯的SCI期刊，在行業細分領域中學術影響力較大，專業度認可很高，所以對原創文章要求創新性較高，如果您的文章質量很高，可以嘗試。平均審稿速度 較慢,18-36周 ，影響因子指數3.5，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。